Literature DB >> 21844472

Keratitis-ichthyosis-deafness syndrome: response to alitretinoin and review of literature.

Siegfried Werchau, Ferdinand Toberer, Alexander Enk, Peter Helmbold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21844472     DOI： 10.1001/archdermatol.2011.216

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  6 in total

Review 1.  [Off-label use of alitretinoin].

Authors:  K Fritz; G S Tiplica; C Salavastru; M Onder
Journal:  Hautarzt       Date:  2013-10       Impact factor: 0.751

Review 2.  Pathogenesis-based therapies in ichthyoses.

Authors:  Joey E Lai-Cheong; Peter M Elias; Amy S Paller
Journal:  Dermatol Ther       Date:  2013 Jan-Feb       Impact factor: 2.851

3.  Connexin hemichannels influence genetically determined inflammatory and hyperproliferative skin diseases.

Authors:  Noah A Levit; Thomas W White
Journal:  Pharmacol Res       Date:  2015-07-23       Impact factor: 7.658

4.  Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents.

Authors:  Andrea L Zaenglein; Moise L Levy; Nicole S Stefanko; Latanya T Benjamin; Anna L Bruckner; Keith Choate; Brittany G Craiglow; John J DiGiovanna; Lawrence F Eichenfield; Peter Elias; Philip Fleckman; Leslie P Lawley; Richard A Lewis; Anne W Lucky; Erin F Mathes; Leonard M Milstone; Amy S Paller; Sonali S Patel; Dawn H Siegel; Joyce Teng; Sherry A Tanumihardjo; Lauren Thaxton; Mary L Williams
Journal:  Pediatr Dermatol       Date:  2020-11-10       Impact factor: 1.588

5.  Alitretinoin in Dermatology-An Update.

Authors:  Aditya Kumar Bubna
Journal:  Indian J Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.494

6.  Alitretinoin reduces erythema in inherited ichthyosis.

Authors:  Giuliana Onnis; Christine Chiaverini; Geoffroy Hickman; Isabelle Dreyfus; Judith Fischer; Emmanuelle Bourrat; Juliette Mazereeuw-Hautier
Journal:  Orphanet J Rare Dis       Date:  2018-04-04       Impact factor: 4.123
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.